Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd announced a change in the director’s interest, specifically regarding Dr. Sergio Scrofani’s securities. On November 25, 2025, Dr. Scrofani acquired 23,983 options exercisable at $4.69, expiring on November 24, 2029, following shareholder approval. This change reflects the company’s ongoing governance and shareholder engagement, potentially impacting its strategic direction and stakeholder confidence.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. Its primary product offerings are centered around innovative cancer treatment solutions, aiming to address unmet medical needs in oncology.
Average Trading Volume: 546,429
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$514.5M
For an in-depth examination of RAC stock, go to TipRanks’ Overview page.